Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-01-02 @ 5:00 PM
Study NCT ID:
NCT02162758
Status:
TERMINATED
Last Update Posted:
2017-05-11
First Post:
2014-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07
Start Date Type:
None
Primary Completion Date:
2016-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-10
First Submit QC Date:
None
Study First Post Date:
2014-06-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-31
Results First Submit QC Date:
None
Results First Post Date:
2017-05-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-31
Last Update Post Date:
2017-05-11
Last Update Post Date Type:
ACTUAL